Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Relationship between body mass index and different domains of disability in older persons: the 3C study
- S. Larrieu, K. Pérès, +6 authors P. Barberger-Gateau
- Medicine
- International Journal of Obesity
- 1 December 2004
OBJECTIVE: To study the relationships between body mass index (BMI) and different domains of disability in elderly subjects from the French 3C study.SETTING: Three cities in France: Bordeaux… Expand
Efficacy of Daflon 500 mg in the Treatment of Lymphedema (Secondary to Conventional Therapy of Breast Cancer)
- A. Pecking, B. Février, C. Wargon, G. Pillion
- Medicine
- Angiology
- 1 January 1997
To assess the activity of a purified, micronized, flavonoidic fraction (Dios; Daflon® 500 mg*) on upper limb lymphedema occurring after breast cancer therapy, a monocenter, randomized, double-blind,… Expand
Cardiovascular variability after rilmenidine challenge: assessment of acute dosing effects by means of spectral analysis
- A. Girard, B. Février, J. Elghozi
- Medicine
- Fundamental & clinical pharmacology
- 8 July 1995
Summary— Short‐term fluctuations in blood pressure (BP) and heart rate (HR) were analysed in a group of twelve subjects with mild hypertension. Indirect finger BP was measured by a Finapres® device.… Expand
Lipid Profile and Antihypertensive Efficacy in Hyperlipidemic Hypertensive Patients: Comparison of Rilmenidine and Captopril
- M. Scemama, B. Février, I. Beucler, F. Dairou
- Medicine
- Journal of cardiovascular pharmacology
- 1995
In hypertensive patients with lipid abnormalities, an ideal antihypertensive agent would control blood pressure without interfering with lipid metabolism. The aim of the present study was to assess… Expand
Peer Support and Psychosocial Pain Management Strategies for Children with Systemic Lupus Erythematosus
- L. Nabors, Teminijesu John Ige, B. Février
- Medicine
- Journal of immunology research
- 25 October 2015
This paper reviews information on Systemic Lupus Erythematosus (SLE) in children. Children with this chronic illness often experience pain related to their condition. They also can experience social… Expand
Efficacy of Daflon 500 mg in Venous Leg Ulcer Healing: A Double-Blind, Randomized, Controlled Versus Placebo Trial in 107 Patients
- J. Guilhou, O. Dereure, +11 authors D. Dubeaux
- Medicine
- Angiology
- 1 January 1997
The objective of this study was to evaluate the efficacy of Daflon® 500 mg (Dios)* in venous ulcers. A multicenter, double-blind, randomized, controlled versus placebo (Plac) trial was conducted,… Expand
Laser Doppler and transcutaneous oximetry: modern investigations to assess drug efficacy in chronic venous insufficiency.
- G. Belcaro, M. Cesarone, +5 authors P. de Gregoris
- Medicine
- International journal of microcirculation…
- 1995
During chronic venous insufficiency (CVI), microcirculatory changes, e.g. a decrease in transcutaneous oxygen pressure (tcpO2) and an increase in transcutaneous carbon dioxide pressure (tcpCO2), are… Expand
Characteristics of undiagnosed diabetes in community-dwelling French elderly: the 3C study.
- I. Bourdel-Marchasson, C. Helmer, +4 authors J. Dartigues
- Medicine
- Diabetes research and clinical practice
- 1 May 2007
We aimed to assess clinical and socio-demographic characteristics of undiagnosed diabetes, including glucose control, in French community-living elderly people. Diagnosed and undiagnosed diabetes,… Expand
Long-term control of blood pressure by rilmenidine in high-risk populations.
- G. Pillion, B. Février, P. Codis, D. Schutz
- Medicine
- The American journal of cardiology
- 22 December 1994
Efficacy and acceptability of rilmenidine in populations with high cardiovascular risk has been established in short- or mid-term studies (1.5-6 months) enrolling relatively small numbers of… Expand
[Effects of rilmenidine (hyperium) on lipid balance in hyperlipidemic hypertensive patients. Randomized, controlled, double-blind 8-week study vs. captopril in parallel groups].
- M. Scemama, B. Février, I. Beucler, F. Dairou
- Medicine
- Annales de cardiologie et d'angeiologie
- 1 December 1996
Rilmenidine (dose of 1 mg once or twice a day) is the first oxazoline compound with antihypertensive properties. Its effects on lipid parameters [total cholesterol, HDL and LDL fractions,… Expand